Technology ID
TAB-2644
Methods of Detecting and Identifying Both Known and Novel Influenza Viruses
E-Numbers
E-274-2013-0
Lead Inventor
Tong, Suxiang (Sue) (CDC)
Co-Inventors
Rogers, Shannon (CDC)
Applications
Diagnostics
Therapeutic Areas
Infectious Disease
Development Status
- Pre-clinical
- In vitro data available
Lead IC
CDC
ICs
CDC
This invention describes materials and methods of detecting novel influenza virus in a sample. As highlighted by the recent H1N1 pandemic strain, influenza viruses are constantly evolving and novel reassortments can quickly spread around the world.
The reagents and methods of this particular technology are capable of detecting any type of influenza virus (such as influenza A virus, influenza B virus, and influenza C virus) in a sample, including novel or previously unknown influenza viruses. Such methods and compositions are useful for diagnosing influenza virus infection in humans and animals.
The reagents and methods of this particular technology are capable of detecting any type of influenza virus (such as influenza A virus, influenza B virus, and influenza C virus) in a sample, including novel or previously unknown influenza viruses. Such methods and compositions are useful for diagnosing influenza virus infection in humans and animals.
Commercial Applications
- Method of rapid, accurate subtype-screening of influenza viruses using "pan-influenza" RT-PCR
- Diagnostic tool for clinicians, veterinarians, public health programs, food-safety officials, researchers and forensic scientists
Competitive Advantages
- A full-spectrum, sensitive and specific assay for identification of influenza viruses, known and novel
- Easily adaptable for commercial production
Licensing Contact: